Literature DB >> 23795711

Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma.

Philippe Armand1, Yasuhiro Oki, Donna S Neuberg, Malek Faham, Craig Cummings, Mark Klinger, Li Weng, Sangeetha Bhattar, Ann S Lacasce, Eric D Jacobsen, Matthew S Davids, Caron Jacobson, David C Fisher, Jennifer R Brown, Nathan H Fowler, M Alma Rodriguez, Michael J Wallace, Sattva S Neelapu, Scott Rodig, Anas Younes, Arnold S Freedman.   

Abstract

Entities:  

Keywords:  lymphomas; minimal residual disease; sequences

Mesh：

Substances：

Year:  2013        PMID： 23795711     DOI： 10.1111/bjh.12439

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  33 in total

Review 1.  Genomics of aggressive B-cell lymphoma.

Authors:  Allison Rosenthal; Lisa Rimsza
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival.

Authors:  Aaron C Logan; Nikita Vashi; Malek Faham; Victoria Carlton; Katherine Kong; Ismael Buño; Jianbiao Zheng; Martin Moorhead; Mark Klinger; Bing Zhang; Amna Waqar; James L Zehnder; David B Miklos
Journal:  Biol Blood Marrow Transplant       Date:  2014-04-24       Impact factor: 5.742

Review 3.  FDG PET-CT in follicular lymphoma: a case-based evidence review.

Authors:  Stephen D Smith; Mary Redman; Kieron Dunleavy
Journal:  Blood       Date:  2014-12-19       Impact factor: 22.113

4.  Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study.

Authors:  Mark Roschewski; Kieron Dunleavy; Stefania Pittaluga; Martin Moorhead; Francois Pepin; Katherine Kong; Margaret Shovlin; Elaine S Jaffe; Louis M Staudt; Catherine Lai; Seth M Steinberg; Clara C Chen; Jianbiao Zheng; Thomas D Willis; Malek Faham; Wyndham H Wilson
Journal:  Lancet Oncol       Date:  2015-04-01       Impact factor: 41.316

5.  Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis.

Authors:  Elodie Bohers; Pierre Julien Viailly; Sydney Dubois; Philippe Bertrand; Catherine Maingonnat; Sylvain Mareschal; Philippe Ruminy; Jean-Michel Picquenot; Christian Bastard; Fabienne Desmots; Thierry Fest; Karen Leroy; Hervé Tilly; Fabrice Jardin
Journal:  Haematologica       Date:  2015-03-06       Impact factor: 9.941

6.  Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.

Authors:  David M Kurtz; Michael R Green; Scott V Bratman; Florian Scherer; Chih Long Liu; Christian A Kunder; Kazuhiro Takahashi; Cynthia Glover; Colm Keane; Shingo Kihira; Brendan Visser; Jason Callahan; Katherine A Kong; Malek Faham; Karen S Corbelli; David Miklos; Ranjana H Advani; Ronald Levy; Rodney J Hicks; Mark Hertzberg; Robert S Ohgami; Maher K Gandhi; Maximilian Diehn; Ash A Alizadeh
Journal:  Blood       Date:  2015-04-17       Impact factor: 22.113

Review 7.  Updates on Circulating Tumor DNA Assessment in Lymphoma.

Authors:  Justin M Darrah; Alex F Herrera
Journal:  Curr Hematol Malig Rep       Date:  2018-10       Impact factor: 3.952

Review 8.  Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

Authors:  Mark Roschewski; Louis M Staudt; Wyndham H Wilson
Journal:  Blood       Date:  2016-04-14       Impact factor: 22.113

9.  Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach.

Authors:  Yasuhiro Oki; Sattva S Neelapu; Michelle Fanale; Larry W Kwak; Luis Fayad; Maria A Rodriguez; Michael Wallace; Mark Klinger; Victoria Carlton; Katherine Kong; Malek Faham; Anas Younes
Journal:  Br J Haematol       Date:  2015-03-29       Impact factor: 6.998

Review 10.  Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.

Authors:  Mary Kwok; S Peter Wu; Clifton Mo; Thomas Summers; Mark Roschewski
Journal:  Curr Treat Options Oncol       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.